AKT1 and neoplasm: The precise mechanism by which berberine exerts its anti-tumor effects is still debatable [11,12], and many signaling pathways, such as β-catenin [10,11,12], AMPK [14] and PI3K-AKT [18], among other mechanisms [13,19], have been implicated.